Remove news-center world-pharmaceutical-news pharmaceuticals-and-the-environment
article thumbnail

Top tweets: Covid-19 headed towards seasonality – and more

Pharmaceutical Technology

Pharmaceutical Technology lists five of the top tweets on infectious diseases in Q2 2022 based on data from GlobalData’s Pharmaceuticals Influencer Platform. Since a surge is seen roughly every six months, experts are trying to establish if it is due to human behaviour or due to the weather and environment. Likes: 521.

article thumbnail

Where are the hottest drug discovery hubs in the US?

Drug Discovery World

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Of these three societal pillars, it is, perhaps surprisingly, business that has stepped up to the plate most assuredly in 2020 – led by some of the world’s strongest brands. Simple kindness is one such comfort blanket. Non-pharma brands leading by example.

article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Cell and gene therapies. There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . billion, compared to $19.9

article thumbnail

Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine

The Pharma Data

Pneumococcal serotypes not in the currently licensed conjugate vaccine, such as 22F and 33F, are among the most common serotypes causing invasive pneumococcal disease in parts of the world, including the U.S., Results from both studies are based on opsonophagocytic activity (OPA) responses – a measure of vaccine-induced functional antibodies.

article thumbnail

Top 10 Medical Device Companies in 2023 by Revenue Statistics and Trends

XTalks

As technology continues to revolutionize every sector of our lives, the medical device industry stands at the forefront of this innovation, playing a pivotal role in enhancing patient care, improving diagnostic accuracy and transforming treatment modalities. Note: When it comes to companies that report in foreign currencies, the conversion to U.S.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

due to updated safety information or addition of new analysis. This can be a lengthy and complex process which must ensure participants are fully informed of all aspects pertaining to the trial. Along the study, patients are usually reconsented multiple times following a change in the trial protocol, eg. Informed consent in the future.